Sign In
Buy NICE
$94.91
-2.14 (-2.21%)
At Close: Jun 03, 2026
~ PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children and
Is Nice (NICE) a Buy as Wall Street Analysts Look Optimistic?
10:30am, Thursday, 19'th Dec 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Why Nice (NICE) is a Top Momentum Stock for the Long-Term
10:56am, Friday, 13'th Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Nice (NICE) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 13'th Dec 2024
Recently, Zacks.com users have been paying close attention to Nice (NICE). This makes it worthwhile to examine what the stock has in store.
Illinois' McHenry County State's Attorney's Office Embraces Digital Transformation with NICE Justice AI-Powered Evidence Management
08:30am, Thursday, 12'th Dec 2024
HOBOKEN, N.J.--(BUSINESS WIRE)-- #Evidencentral--NICE (Nasdaq: NICE) today announced that the McHenry County (IL) State's Attorney's Office will be deploying NICE Justice digital evidence management,
Monterey County District Attorney's Office Selects NICE Justice AI-powered Digital Evidence Management
07:30am, Thursday, 12'th Dec 2024
HOBOKEN, N.J.--(BUSINESS WIRE)-- #Evidencentral--NICE (Nasdaq: NICE) today announced that the Monterey County District Attorney's Office in California has selected NICE Justice, one of the AI-powered
NICE Gains 11% in 3 Months: Should You Buy, Sell or Hold the Stock?
01:35pm, Wednesday, 11'th Dec 2024
NICE leads in customer engagement with CXone. However, it faces challenges from stiff competition and a revenue decline in the APAC region.
Prosper Creates Exceptional CX with Industry-Leading NICE CXone Mpower
08:00am, Monday, 09'th Dec 2024
HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NICE (Nasdaq: NICE) today announced that Prosper, a financial services company, has selected NICE as their CX transformation partner. With a breadth of enterprise
Nice (NICE) Recently Broke Out Above the 200-Day Moving Average
10:31am, Thursday, 05'th Dec 2024
After reaching an important support level, Nice (NICE) could be a good stock pick from a technical perspective. NICE surpassed resistance at the 200-day moving average, suggesting a long-term bullish
Here's Why Nice (NICE) is a Strong Growth Stock
10:51am, Wednesday, 04'th Dec 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NICE Reports 80% YOY Increase in Digital Interactions for Retailers Over Black Friday and Cyber Monday Shopping Weekend
08:30am, Wednesday, 04'th Dec 2024
HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NICE (Nasdaq: NICE) today announced that its CXone MPower AI hyper platform managed a record number of automated customer interactions during the Black Friday and
Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
08:05am, Wednesday, 04'th Dec 2024
First positive reimbursement decision worldwide for LYTENAVA™; First launch anticipated in H1 2025 LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment
NICE Releases Environmental, Social and Governance (ESG) Report, Showcasing Power of Automation in Driving Exceptional Experiences
08:00am, Wednesday, 04'th Dec 2024
HOBOKEN, N.J.--(BUSINESS WIRE)-- #NICELtd--NICE (Nasdaq: NICE) today announced the release of its 2023 Environmental, Social, and Governance (ESG) report, highlighting its accomplishments in advancing
Nice Is An Excellent AI Opportunity In Client Management Software
07:42am, Tuesday, 03'rd Dec 2024
Nice Ltd has struggled recently due to its CEO's retirement and geopolitical issues but is on a recovery path with AI-driven efficiency. Nice's AI-equipped customer support platform, providing its cus
Nice (NICE) Just Overtook the 20-Day Moving Average
03:27pm, Monday, 02'nd Dec 2024
After reaching an important support level, Nice (NICE) could be a good stock pick from a technical perspective. NICE surpassed resistance at the 20-day moving average, suggesting a short-term bullish
